Browse All Providers

Find a Provider Near You

Find A Provider
Browse All Specialties

Learn more about a specialty

Find A Specialty
Accepted Insurance

Check to see if your insurance plan is accepted by CU Medicine Clinics.

Check for Insurance

Practice Locations

UCHealth Tony Grampsas Urologic Cancer Care Clinic - Anschutz Medical Campus
1665 Aurora Ct 1st Floor, Aurora, CO 80045

720-848-0170

Laura Graham, MD

Medical Oncology

Board Certified

Schedule Appointment

  • Title(s)

    Assistant Professor

  • Gender

    Female

  • Department

    Assistant Professor, Medicine-Medical Oncology

  • Specialty

    Medical Oncology, Internal Medicine

  • Primary Clinic Phone

    720-848-0170

  • Hospital Affiliations

    University of Colorado Hospital
Print Share

Referring Provider Info

Locations

Practice Locations

UCHealth Tony Grampsas Urologic Cancer Care Clinic - Anschutz Medical Campus
1665 Aurora Ct, 1st Floor
Aurora, CO 80045

720-848-0170

Get directions

Provider Expertise

Care Philosophy

My approach to care centers on building a true partnership with each patient and family, grounded in clear and direct communication, compassion, and respect for individual goals and values. As a medical oncologist specializing in genitourinary cancers, I aim to provide evidence-based, personalized treatment while helping patients navigate complex decisions with confidence. I am deeply committed to advancing the field through clinical trials and translational research, with a focus on innovative therapies and understanding why treatments work for some patients and not others. By integrating cutting-edge science with attentive, whole-person care, I strive to offer patients access to the most promising options today while contributing to better treatments for the future. I am seeing patients with prostate cancer, testicular (germ cell) cancer, adrenal cortical cancer, bladder/urothelial cancer, kidney cancer, and rare genitourinary cancers.


Specialties

  • Medical Oncology ( 2021 )
  • Internal Medicine ( 2018 )

Conditions & Treatments

  • Cancers

    Bladder Cancer, Kidney Cancer, Prostate Cancer, Testicular Cancer, Urologic Cancer

Education & Training

Medical Schools

MD, Rush Medical College of Rush University Medical Center (2015)


Undergraduate Schools

BA, University of Chicago (IL) (2009)


Residency Program

University of Washington Program (2018)


Fellowships

University of Washington Program (2021)

Professional Memberships

American Society of Clinical Oncology (ASCO), Member


Research & Grants

Research Interests for Patients

My research focuses on developing more effective treatments for advanced prostate cancer and other genitourinary malignancies through innovative clinical trials and translational science. I am particularly interested in hormone-based therapies, immunotherapy combinations, and T-cell–directed approaches aimed at overcoming treatment resistance and improving durable responses. My work integrates patient care with laboratory investigation, including analyses of blood and tumor samples to better understand how therapies reshape the tumor immune microenvironment and to identify biomarkers that predict which patients are most likely to benefit. I collaborate closely with multidisciplinary academic teams, cooperative groups, and industry partners to accelerate the development of personalized therapies and to translate promising scientific discoveries into meaningful advances for patients with genitourinary cancers.

information for referring providers

Referral Contact Phone

720-848-0170

Referring Patients Link

Information for Referring and Transferring Patients

Clinical Interests for Referring Providers

My clinical interests include all GU malignancies, in particular germ cell tumors, adrenal cortical carcinoma, and prostate cancer. I serve on the National Comprehensive Cancer Network (NCCN) Guideline Panel for testicular/germ cell tumors.

Research Interest for Referring Providers

My research interests focus on improving outcomes for patients with advanced prostate cancer through the development and study of novel therapeutic strategies. My research program is centered on two complementary areas: (1) clinical trials evaluating innovative treatments, including hormone-based therapies and immunotherapy combinations such as T-cell–directed approaches, particularly for patients with treatment-resistant disease, and (2) translational studies that analyze blood and tumor samples to understand mechanisms of response and resistance, identify predictive biomarkers, and optimize patient selection. Through these efforts, I aim to expand effective treatment options, personalize therapy, and provide patients with access to promising investigational approaches, working in close collaboration with multidisciplinary teams, referring providers, and other partners.